BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Di Carlo C, Brandi J, Cecconi D. Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma. World J Stem Cells 2018; 10(11): 172-182 [PMID: 30631392 DOI: 10.4252/wjsc.v10.i11.172]
URL: https://www.wjgnet.com/1948-0210/full/v10/i11/172.htm
Number Citing Articles
1
Eun-Young Kim, Seong-Uk Lee, Yoon Hee Kim. 1,2,3,4,6-Penta-O-galloyl-β-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell lineAnimal Cells and Systems 2022; 26(6): 328 doi: 10.1080/19768354.2022.2152864
2
A S M Mahadiuzzaman, F.A. Dain Md Opo, Saleh Alkarim. Stem cell-based targeted therapy in pancreatic cancer: Current approaches and future prospectsTissue and Cell 2024; 89: 102449 doi: 10.1016/j.tice.2024.102449
3
Abhishek Dutta, Swastika Paul. Exosome‐based cancer stem cell communication: Implication for detecting and eliminating cancer stem cellsMedComm – Future Medicine 2022; 1(2) doi: 10.1002/mef2.23
4
Ntombikayise Xelwa, Geoffrey Patrick Candy, John Devar, Jones Omoshoro-Jones, Martin Smith, Ekene Emmanuel Nweke. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting ChemoresistanceFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.683788
5
Hem D Shukla, Tijana Dukic, Sanjit Roy, Binny Bhandary, Andrew Gerry, Yannick Poirier, Narottam Lamichhane, Jason Molitoris, France Carrier, Aditi Banerjee, William F. Regine, Jerimy C. Polf. Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment responseFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1072774
6
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer2019; : 325 doi: 10.1016/B978-0-12-819457-7.00016-5
7
António M. Palma, Vignesh Vudatha, Maria Leonor Peixoto, Esha Madan. Pancreatic Cancer: Basic Mechanisms and TherapiesAdvances in Cancer Research 2023; 159: 203 doi: 10.1016/bs.acr.2023.02.005
8
Giulia Ambrosini, Elisa Dalla Pozza, Giuseppina Fanelli, Claudia Di Carlo, Andrea Vettori, Giuseppe Cannino, Chiara Cavallini, Cristian Andres Carmona-Carmona, Jessica Brandi, Sara Rinalducci, Maria Teresa Scupoli, Andrea Rasola, Daniela Cecconi, Marta Palmieri, Ilaria Dando. Progressively De-Differentiated Pancreatic Cancer Cells Shift from Glycolysis to Oxidative Metabolism and Gain a Quiescent Stem StateCells 2020; 9(7): 1572 doi: 10.3390/cells9071572
9
Eric Russ, Krithika Bhuvaneshwar, Guisong Wang, Benjamin Jin, Michele M. Gage, Subha Madhavan, Yuriy Gusev, Geeta Upadhyay. High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinomaOncotarget 2021; 12(3): 145 doi: 10.18632/oncotarget.27880
10
Debasmita Dutta, Priyanka Ray, Archana De, Arnab Ghosh, Raj Shankar Hazra, Pratyusha Ghosh, Snigdha Banerjee, Francisco J. Diaz, Sunil P. Upadhyay, Mohiuddin Quadir, Sushanta K. Banerjee, Pankaj K. Singh. pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse modelPLOS ONE 2024; 19(4): e0297749 doi: 10.1371/journal.pone.0297749
11
Md. Hafiz Uddin, Dingqiang Zhang, Irfana Muqbil, Bassel F. El-Rayes, Herbert Chen, Philip A. Philip, Asfar S. Azmi. Deciphering cellular plasticity in pancreatic cancer for effective treatmentsCancer and Metastasis Reviews 2024; 43(1): 393 doi: 10.1007/s10555-023-10164-5
12
Xiaoqing Wang, Honghao Song, Junyu Liang, Yang Jia, Yongfei Zhang. Abnormal expression of HADH, an enzyme of fatty acid oxidation, affects tumor development and prognosis (Review)Molecular Medicine Reports 2022; 26(6) doi: 10.3892/mmr.2022.12871
13
Joseph W. Franses, Julia Philipp, Pavlos Missios, Irun Bhan, Ann Liu, Chittampalli Yashaswini, Eric Tai, Huili Zhu, Matteo Ligorio, Benjamin Nicholson, Elizabeth M. Tassoni, Niyati Desai, Anupriya S. Kulkarni, Annamaria Szabolcs, Theodore S. Hong, Andrew S. Liss, Carlos Fernandez-del Castillo, David P. Ryan, Shyamala Maheswaran, Daniel A. Haber, George Q. Daley, David T. Ting. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug targetNature Communications 2020; 11(1) doi: 10.1038/s41467-020-17150-3
14
Xiao-Yan Huang, Wen-Tao Qin, Qi-Sheng Su, Cheng-Cheng Qiu, Ruo-Chuan Liu, Shan-Shan Xie, Yang Hu, Shang-Yong Zhu, Xiaoping Liu. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal AdenocarcinomaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/6669570
15
Alireza Shokouhifar, Javad Firouzi, Masoumeh Nouri, Gholamreza Anani Sarab, Marzieh Ebrahimi. NK cell upraise in the dark world of cancer stem cellsCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02400-1
16
Giuliana Siragusa, Jessica Brandi, Tristan Rawling, Michael Murray, Daniela Cecconi. Triphenylphosphonium-Conjugated Palmitic Acid for Mitochondrial Targeting of Pancreatic Cancer Cells: Proteomic and Molecular EvidenceInternational Journal of Molecular Sciences 2024; 25(12): 6790 doi: 10.3390/ijms25126790
17
Mukulika Bose, Alexa Sanders, Aashna Handa, Aabha Vora, Manuel R. Cardona, Cory Brouwer, Pinku Mukherjee. Molecular crosstalk between MUC1 and STAT3 influences the anti-proliferative effect of Napabucasin in epithelial cancersScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-53549-4
18
Marcello Manfredi, Jessica Brandi, Claudia Di Carlo, Virginia Vita Vanella, Elettra Barberis, Emilio Marengo, Mauro Patrone, Daniela Cecconi. Mining cancer biology through bioinformatic analysis of proteomic dataExpert Review of Proteomics 2019; 16(9): 733 doi: 10.1080/14789450.2019.1654862
19
Claudia Di Carlo, Bebiana C. Sousa, Marcello Manfredi, Jessica Brandi, Elisa Dalla Pozza, Emilio Marengo, Marta Palmieri, Ilaria Dando, Michael J. O. Wakelam, Andrea F. Lopez-Clavijo, Daniela Cecconi. Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cellsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92752-5
20
Ravi Gor, Ilangovan Ramachandran, Satish Ramalingam. Targeting the Cancer Stem Cells in Endocrine Cancers with PhytochemicalsCurrent Topics in Medicinal Chemistry 2022; 22(31): 2589 doi: 10.2174/1567205020666221114112814
21
Seung Wan Son, Mun Gyu Song, Ba Da Yun, Jong Kook Park. Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic CancerBiomedicines 2021; 9(3): 263 doi: 10.3390/biomedicines9030263
22
Mariafausta Fischietti, Frank Eckerdt, Gavin T. Blyth, Ahmet D. Arslan, William M. Mati, Chidera V. Oku, Ricardo E. Perez, Catalina Lee-Chang, Ewa M. Kosciuczuk, Diana Saleiro, Elspeth M. Beauchamp, Maciej S. Lesniak, Daniela Verzella, Leyu Sun, Eleanor N. Fish, Guang-Yu Yang, Wenan Qiang, Leonidas C. Platanias. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinomaOncogene 2021; 40(18): 3273 doi: 10.1038/s41388-021-01761-1
23
Shuang Zhou, Renle Du, Zhenglu Wang, Wenzhi Shen, Ruifang Gao, Shan Jiang, Yan Fang, Yuzhi Shi, Antao Chang, Lei Liu, Chenghu Liu, Na Li, Rong Xiang. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinomaCancer Medicine 2019; 8(5): 2325 doi: 10.1002/cam4.2070
24
Giuseppe Nicolò Fanelli, Antonio Giuseppe Naccarato, Cristian Scatena. Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic OptimizationFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00569
25
Archana P. Thankamony, Kritika Saxena, Reshma Murali, Mohit Kumar Jolly, Radhika Nair. Cancer Stem Cell Plasticity – A Deadly DealFrontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.00079
26
Kah Keng Wong. DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implicationsCellular Oncology 2020; 43(5): 779 doi: 10.1007/s13402-020-00526-4
27
Akimasa Seno, Said M. Afify, Ghmkin Hassan, Masaharu Seno. iPSC Derived Progenitors2022; : 265 doi: 10.1016/B978-0-323-85545-7.00002-8
28
Catalina M. Perelló-Reus, Teresa Rubio-Tomás, Eugenia Cisneros-Barroso, Lesly Ibargüen-González, Juan José Segura-Sampedro, Rafael Morales-Soriano, Carles Barceló. Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiotaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.995357
29
Hesham A. El-Mahdy, Ahmed A. El-Husseiny, Yasser I. Kandil, Ayman M. Gamal El-Din. Diltiazem potentiates the cytotoxicity of gemcitabine and 5-fluorouracil in PANC-1 human pancreatic cancer cells through inhibition of P-glycoproteinLife Sciences 2020; 262: 118518 doi: 10.1016/j.lfs.2020.118518
30
Jyothi Priya Mandala, Srinivas Pittala, Gowru Srivani. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers2020; : 51 doi: 10.1007/978-3-030-48405-7_3
31
Andreea Nedelcu, Teodora Mocan, Cristiana Grapa, Lucian Mocan. Recent Advances in Nanoparticle-Mediated Diagnosis and the Treatment of Pancreatic CancerInternational Journal of Molecular Sciences 2021; 22(15): 8060 doi: 10.3390/ijms22158060
32
Sabina Quader, Shihori Tanabe, Horacio Cabral. Cancer Stem Cell Markers and Related Network PathwaysAdvances in Experimental Medicine and Biology 2022; 1393: 141 doi: 10.1007/978-3-031-12974-2_7
33
Andreia S. Fernandes, Catarina Oliveira, Rui L. Reis, Albino Martins, Tiago H. Silva. Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer TherapiesMarine Drugs 2022; 20(11): 689 doi: 10.3390/md20110689
34
Ashleigh R. Poh, Matthias Ernst. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical ChallengesCancers 2021; 13(12): 2860 doi: 10.3390/cancers13122860
35
Benedetta Ferrara, Erica Dugnani, Valeria Sordi, Valentina Pasquale, Silvia Pellegrini, Michele Reni, Gianpaolo Balzano, Lorenzo Piemonti. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2022; 23(18): 10663 doi: 10.3390/ijms231810663